Orphan Europe, part of the Recordati Group, is a pharmaceutical company that develops and distributes orphan drugs for the treatment of rare diseases. Whether you are a physician seeking help and support in your fight to treat a rare disease, a patient looking for information or a company looking for a partnership – Orphan Europe is waiting to hear from you.

Feature story


	ESPGHAN - Satellite Symposium Invitation The 12/04/2012 at 17:33:23 Deficiency consequences of lipid malabsorption disorders: Are we able to prevent them? Download here Read the news >>


	Deficiency consequences of lipid malabsorption disorders : are we able to prevent them? Events The 10/04/2012 at 09:36:56 Orphan Europe will organise a satellite symposium during the ESPGHAN Update 2012 meeting in Stockholm on Saturday 28^th April “Deficiency consequences of lipid malabsorption disorders : Are we able to prevent them”. Please come and visit our booth in the exhibition space

Orphan Europe provides treatment for patients suffering from rare diseases all over the world. Read more about the different diseases here.

Orphan Europe has been developing and distributing orphan drugs since 1990 and has today an extensive product portfolio. Read more about some of the orphan medicinal products provided by Orphan Europe.

Provides high-quality, innovative science education for healthcare personnel involved in the diagnosis and management of patients affected by rare diseases.

| Design by Cyim 2007

Feature story

ESPGHAN - Satellite Symposium Invitation

Deficiency consequences of lipid malabsorption disorders : are we able to prevent them?